Multiple factors unrelated to the medication may cause respiratory symptoms, including underlying cardiovascular disease, obesity-related conditions like sleep apnea, worsening GERD from delayed gastric emptying, anxiety or panic attacks, concurrent medications affecting breathing, or unrelated respiratory infections
Compounded tirzepatide is only available if their brand name equivalent medications are listed in the FDA shortage list
Reduced appetite while therapeutically intended, this can occasionally lead to inadequate nutritional intake Injection site reactions mild redness, bruising, or discomfort at the site of subcutaneous injection Fatigue and dizziness reported in a subset of trial participants, often associated with early treatment phases Hypoglycaemia (low blood sugar) uncommon with retatrutide alone, but the risk increases when it is used alongside insulin or sulfonylureas
Persistent nausea or vomiting can lead to dehydration, kidney problems, or malnutrition in some cases
It is important to follow the recommended dosage instructions and consult a healthcare professional for personalized advice and guidance regarding your specific health needs and immune system support goals
W., Whiteman, D